ZUH:CA:TSX-BMO Equal Weight US Health Care (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 64.91

Change

-1.15 (-1.74)%

Market Cap

CAD 0.22B

Volume

2.05K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-11 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-0.16 (-0.39%)

CAD 3.37B
ZWU:CA BMO Covered Call Utilities ETF

-0.07 (-0.63%)

CAD 1.80B
XIT:CA iShares S&P/TSX Capped Informa..

-0.02 (-0.03%)

CAD 0.89B
TXF:CA First Asset Tech Giants Covere..

-0.01 (-0.05%)

CAD 0.67B
HTA:CA Harvest Tech Achievers Growth ..

-0.05 (-0.30%)

CAD 0.63B
XHC:CA iShares Global Healthcare (CAD..

-0.70 (-1.01%)

CAD 0.56B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.05 (+0.23%)

CAD 0.49B
XUT:CA iShares S&P/TSX Capped Utiliti..

-0.09 (-0.32%)

CAD 0.37B
CWW:CA iShares Global Water Common Cl..

-0.83 (-1.37%)

CAD 0.30B
HUTL:CA Harvest Equal Weight Global Ut..

-0.19 (-1.06%)

CAD 0.27B

ETFs Containing ZUH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.22% 47% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.22% 47% F 41% F
Trailing 12 Months  
Capital Gain -9.77% 14% F 15% F
Dividend Return 0.68% 25% F 8% B-
Total Return -9.10% 6% D- 14% F
Trailing 5 Years  
Capital Gain 31.40% 34% F 42% F
Dividend Return 3.36% 18% F 4% F
Total Return 34.76% 11% F 32% F
Average Annual (5 Year Horizon)  
Capital Gain 2.68% 31% F 42% F
Dividend Return 3.09% 17% F 35% F
Total Return 0.42% 26% F 23% F
Risk Return Profile  
Volatility (Standard Deviation) 15.47% 66% D+ 55% F
Risk Adjusted Return 20.00% 17% F 33% F
Market Capitalization 0.22B 62% D 47% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.